Doubling Down: The Power of Asset Diversification in a Time of Robust Access to Capital
Doubling Down Following up on our recent white paper, Biopharma’s COVID Capital Comeback, here is a look at the greatest risk […]
Doubling Down Following up on our recent white paper, Biopharma’s COVID Capital Comeback, here is a look at the greatest risk […]
Q3 2020 Report: Global Trends in Biopharma Transactions Each quarter our team at Locust Walk compiles key statistics and trends on strategic
SUBSCRIBE TO OUR INSIGHTS Linkedin Twitter Youtube Instagram CATEGORIES Asian Capabilities Capital Raising Commercial Assessment Locust Walk Institute Market Trends
Biopharma’s COVID Capital Comeback What a difference a few months can make – especially during a pandemic. Heading into 2020,
CATEGORIES News Events Publications ARCHIVE Panel Recording: The Unexpected IPO Boom in Biopharma in Q2 Locust Walk partnered with Applied
SUBSCRIBE TO OUR INSIGHTS Linkedin Twitter Youtube Instagram CATEGORIES News Locust Walk Webinar Live Panel: The Unexpected IPO Boom for
Q2 2020 Report: Global Trends in Biopharma Transactions Each quarter, Locust Walk deal team members compile key statistics and trends
SUBSCRIBE TO OUR INSIGHTS Linkedin Twitter Youtube Instagram CATEGORIES Asian Capabilities Capital Raising Commercial Assessment Locust Walk Institute Market Trends
A Brave New World COVID-19 or SARS Cov-2 to be precise, has changed the world in many regards. From the
Deal Makers of Japan, Volume 2 We are pleased to present the second series of the Deal Makers of Japan